Salmaan Kanji profile picture

Contact Information

Salmaan Kanji, BSc, Pharm, PharmD
613 737-8899 ext 78159
skanji@ottawahospital.on.ca

Funding

07/2014-07/2016
Antimicrobial pharmacokinetics in critically ill adults during sustained low efficiency dialysis
Principal: S. Kanji
Funding: The Kidney Foundation of Canada
Funds awarded: $100,000
Years 2

06/2014-06/2015
Implementation of evidenced-based guidelines for the management of pain, agitation and delirium to facilitate early mobilization in the Intensive Care Unit: A Quality Improvement Project
Principal: E. Rosenberg & G. Wolff
Role: Co-investigator
Funding: Department of Medicine (PQ&SC)
Funds awarded: $30,160
Years 1

01/2014-12/2014
Validation of a Pain Assessment Tool (CPOT) in Critically Ill Patients with Delirium
Principal: S. Kanji
Funding: CSHP Foundation, Research Grant
Funds awarded: $8,000
Years 1

01/2014-12/2014
Antimicrobial Pharmacokinetics in Critically Ill Adults during SustainedLow Efficiency Dialysis (SLED)
Principal: R. Patel
Role: Co-investigator
Funding: Ottawa Hospital, Department of Medicine
Developmental Research Grant
Funds awarded: $12,122
Years 1

03/2013-02/2014
The risk of elevated prolactin levels in pediatric patients exposed to risperidone and other antipsychotics for the treatment of schizophrenia and otherschizophrenia spectrum disorders: a network meta-analysis
Principal: D. Moher
Role: Co-investigator
Funding:Canadian Institutes of Health Research
Funds awarded: $96,943
Years 1

03/2013-02/2014
Adding clarity to uncertainty in the study of drug safety
Principal: B. Hutton
Role: Co-investigator
Funding:Canadian Institutes of Health Research
Program: Operating Grant - PA: Drug Safety and Effectiveness (bridge funding) from the Drug Safety and Effectiveness Network (DSEN)
Funding awarded: $100,000
Years 1

02/2013-02/2015
Optimal VAsopressorTItratiON (OVATION) Pilot Randomized controlled Trial
Principal: F. Lamontange
Role: Co-applicant
Funding: Canadian Institutes of Health Research
Funding awarded: $379,078
Years 2